Prestige Consumer Healthcare (PBH) Income from Continuing Operations (2010 - 2025)

Prestige Consumer Healthcare (PBH) recorded quarterly Income from Continuing Operations of 46696000.0 in Q4 2025, up 10.63% quarter-over-quarter from 42211000.0 in Q3 2025, and down 23.49% on a YoY basis from 61032000.0 in Q4 2024.

Prestige Consumer Healthcare (PBH) Income from Continuing Operations (2010 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Income from Continuing Operations history runs 16 years deep, the most recent figure standing at 46696000.0 for Q4 2025.

  • In Q4 2025, Income from Continuing Operations fell 23.49% year-over-year to 46696000.0; the TTM figure through Dec 2025 stood at 186501000.0 (down 12.82% YoY), while the FY2025 annual figure was 214605000.0, up 2.52% from the prior year.
  • Income from Continuing Operations was 46696000.0 for Q4 2025 at Prestige Consumer Healthcare, up from 42211000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 61032000.0 in Q4 2024 to a low of 240552000.0 in Q1 2023.
  • Historically, Income from Continuing Operations has averaged 35945300.0 across 5 years, with a median of 50619000.0 in 2021.
  • The sharpest annual moves came in 2023 and 2024: Income from Continuing Operations plunged 561.84% in 2023, then soared 120.56% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 50215000.0 in 2021, then increased by 3.46% to 51951000.0 in 2022, then grew by 2.11% to 53046000.0 in 2023, then grew by 15.05% to 61032000.0 in 2024, then dropped by 23.49% to 46696000.0 in 2025.
  • The last three Income from Continuing Operations figures came in at 46696000.0 (Q4 2025), 42211000.0 (Q3 2025), and 47466000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 370.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -92.12 Mn
10 Prestige Consumer Healthcare 2.33 Bn 2.26 Bn 157.37 Mn 46.70 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 46.70 Mn
Sep 30, 2025 42.21 Mn
Jun 30, 2025 47.47 Mn
Mar 31, 2025 50.13 Mn
Dec 31, 2024 61.03 Mn
Sep 30, 2024 54.38 Mn
Jun 30, 2024 49.07 Mn
Mar 31, 2024 49.46 Mn
Dec 31, 2023 53.05 Mn
Sep 30, 2023 53.56 Mn
Jun 30, 2023 53.28 Mn
Mar 31, 2023 -240.55 Mn
Dec 31, 2022 51.95 Mn
Sep 30, 2022 51.02 Mn
Jun 30, 2022 55.27 Mn
Mar 31, 2022 52.09 Mn
Dec 31, 2021 50.22 Mn
Sep 30, 2021 45.33 Mn
Jun 30, 2021 57.76 Mn
Mar 31, 2021 35.51 Mn